Jennerex Biotherapeutics' Acquisition

Jennerex Biotherapeutics was acquired by SillaJen on March 18, 2014.

Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead produ…

Articles about Jennerex Biotherapeutics' Acquisition: